• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Letter regarding "Non-alcoholic fatty liver disease: Definition and subtypes".关于“非酒精性脂肪性肝病：定义与亚型”的信函
Clin Mol Hepatol. 2023 Jul;29(3):810-811. doi: 10.3350/cmh.2023.0129. Epub 2023 May 8.
2
Letter regarding "The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults".关于“胰岛素抵抗代谢评分对韩国成年人新发非酒精性脂肪性肝病预测的有用性”的信函
Clin Mol Hepatol. 2023 Jan;29(1):169-170. doi: 10.3350/cmh.2022.0384. Epub 2022 Nov 10.
3
The Interrelationship Among Non-Alcoholic Fatty Liver Disease, Colonic Diverticulosis and Metabolic Syndrome.非酒精性脂肪性肝病、结肠憩室病与代谢综合征之间的相互关系
J Gastrointestin Liver Dis. 2021 Jun 18;30(2):274-282. doi: 10.15403/jgld-3308.
4
Correspondence on Letter regarding "The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults".关于“胰岛素抵抗代谢评分对韩国成年人新发非酒精性脂肪性肝病预测的有用性”的信件往来
Clin Mol Hepatol. 2023 Jan;29(1):179-181. doi: 10.3350/cmh.2022.0409. Epub 2022 Nov 22.
5
On the Proposed Definition of Metabolic-Associated Fatty Liver Disease.关于代谢相关脂肪性肝病的拟议定义。
Clin Gastroenterol Hepatol. 2021 May;19(5):865-870. doi: 10.1016/j.cgh.2021.01.017. Epub 2021 Jan 13.
6
Association of Cardiovascular Risk Factors and Metabolic Syndrome with non-alcoholic and alcoholic fatty liver disease: a retrospective analysis.心血管危险因素和代谢综合征与非酒精性和酒精性脂肪性肝病的关系：一项回顾性分析。
BMC Endocr Disord. 2021 May 1;21(1):91. doi: 10.1186/s12902-021-00758-x.
7
Correspondence on Letter regarding "Non-alcoholic fatty liver disease: Definition and subtypes".关于“非酒精性脂肪性肝病：定义及亚型”信件的通信
Clin Mol Hepatol. 2023 Jul;29(3):817-819. doi: 10.3350/cmh.2023.0155. Epub 2023 May 17.
8
Changing the nomenclature from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease is more than a change in terminology.将术语从非酒精性脂肪性肝病改为代谢功能障碍相关脂肪性肝病，这不仅仅是术语的改变。
Clin Mol Hepatol. 2023 Apr;29(2):371-373. doi: 10.3350/cmh.2023.0086. Epub 2023 Mar 14.
9
Non-alcoholic fatty liver disease and cardiovascular risk: an update.非酒精性脂肪性肝病与心血管风险：最新进展
Expert Rev Gastroenterol Hepatol. 2018 Dec;12(12):1175-1177. doi: 10.1080/17474124.2018.1533117. Epub 2018 Oct 16.
10
Association of nonalcoholic fatty liver disease with incident dementia later in life among elderly adults.老年人群中非酒精性脂肪性肝病与晚年发生痴呆症的关联。
Clin Mol Hepatol. 2022 Jul;28(3):481-482. doi: 10.3350/cmh.2022.0097. Epub 2022 May 16.

引用本文的文献

1
Identification of potentially effective drugs for metabolic dysfunction-associated steatotic liver disease against liver cirrhosis: In-silico drug repositioning-based retrospective cohort study.针对代谢功能障碍相关脂肪性肝病肝硬化的潜在有效药物鉴定：基于计算机辅助药物重定位的回顾性队列研究。
PLoS One. 2025 Jun 4;20(6):e0323880. doi: 10.1371/journal.pone.0323880. eCollection 2025.
2
Metabolic dysfunction-associated steatotic liver disease, metabolic alcohol-related liver disease, and incident dementia: a nationwide cohort study : MASLD, MetALD, and dementia risk.代谢功能障碍相关脂肪性肝病、代谢性酒精性肝病与新发痴呆：一项全国性队列研究：代谢功能障碍相关脂肪性肝病、酒精性肝病与痴呆风险
BMC Gastroenterol. 2025 Apr 29;25(1):308. doi: 10.1186/s12876-025-03814-1.
3
Correspondence on Letter regarding "Non-alcoholic fatty liver disease: Definition and subtypes".关于“非酒精性脂肪性肝病：定义及亚型”信件的通信
Clin Mol Hepatol. 2023 Jul;29(3):817-819. doi: 10.3350/cmh.2023.0155. Epub 2023 May 17.

本文引用的文献

1
Validity of fatty liver prediction scores for diagnosis of fatty liver by Fibroscan.脂肪性肝预测评分对 Fibroscan 诊断脂肪性肝病的有效性。
Hepatobiliary Pancreat Dis Int. 2024 Aug;23(4):353-360. doi: 10.1016/j.hbpd.2023.02.009. Epub 2023 Feb 24.
2
Nonalcoholic fatty liver disease and non-liver comorbidities.非酒精性脂肪性肝病与非肝脏合并症。
Clin Mol Hepatol. 2023 Feb;29(Suppl):s86-s102. doi: 10.3350/cmh.2022.0442. Epub 2023 Jan 5.
3
Non-alcoholic fatty liver disease: Definition and subtypes.非酒精性脂肪性肝病：定义和亚型。
Clin Mol Hepatol. 2023 Feb;29(suppl):S5-S16. doi: 10.3350/cmh.2022.0424. Epub 2022 Dec 28.
4
Non-alcoholic fatty liver disease and the risk of dementia: A meta-analysis of cohort studies.非酒精性脂肪性肝病与痴呆风险：队列研究的荟萃分析
Clin Mol Hepatol. 2022 Oct;28(4):931-932. doi: 10.3350/cmh.2022.0259. Epub 2022 Sep 5.
5
Association of non-alcoholic fatty liver disease with incident dementia later in life among elder adults.非酒精性脂肪肝疾病与老年人晚年痴呆症发病的相关性。
Clin Mol Hepatol. 2022 Jul;28(3):510-521. doi: 10.3350/cmh.2021.0332. Epub 2022 Mar 17.
6
Metabolic Dysfunction-Associated Fatty Liver Disease Better Predicts Incident Cardiovascular Disease.代谢相关脂肪性肝病更好地预测心血管疾病的发生。
Gut Liver. 2022 Jul 15;16(4):589-598. doi: 10.5009/gnl210256. Epub 2021 Nov 3.
7
Development of a simple nonalcoholic fatty liver disease scoring system indicative of metabolic risks and insulin resistance.一种简单的非酒精性脂肪性肝病评分系统的开发，该系统可指示代谢风险和胰岛素抵抗。
Ann Transl Med. 2020 Nov;8(21):1414. doi: 10.21037/atm-20-2951.
8
Lipocalin 2 induces neuroinflammation and blood-brain barrier dysfunction through liver-brain axis in murine model of nonalcoholic steatohepatitis.在非酒精性脂肪性肝炎小鼠模型中，脂质运载蛋白2通过肝脑轴诱导神经炎症和血脑屏障功能障碍。
J Neuroinflammation. 2020 Jul 4;17(1):201. doi: 10.1186/s12974-020-01876-4.
9
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.非酒精性脂肪性肝病的诊断与管理：美国肝病研究协会的实践指南
Hepatology. 2018 Jan;67(1):328-357. doi: 10.1002/hep.29367. Epub 2017 Sep 29.
10
Lipocalin-2 mediates non-alcoholic steatohepatitis by promoting neutrophil-macrophage crosstalk via the induction of CXCR2.脂联素-2 通过诱导 CXCR2 促进中性粒细胞-巨噬细胞串扰来介导非酒精性脂肪性肝炎。
J Hepatol. 2016 Nov;65(5):988-997. doi: 10.1016/j.jhep.2016.05.041. Epub 2016 Jun 4.

Letter regarding "Non-alcoholic fatty liver disease: Definition and subtypes".

作者信息

Jeong Seogsong, Lim Yohwan, Lee Su Kyoung, Han Hyun Wook

机构信息

Department of Biomedical Informatics, CHA University School of Medicine, CHA University, Seongnam, Korea.

Institute of Biomedical Informatics, CHA University School of Medicine, CHA University, Seongnam, Korea.

出版信息

Clin Mol Hepatol. 2023 Jul;29(3):810-811. doi: 10.3350/cmh.2023.0129. Epub 2023 May 8.

DOI:10.3350/cmh.2023.0129
PMID:37157774
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10366794/
Abstract
摘要